Autologous EPCs transfected with human eNOS

BIOLOGICAL2 trials

Sponsors

Ottawa Hospital Research Institute, Northern Therapeutics

Conditions

Anterior Wall Myocardial InfarctionHypertension,Pulmonary

Phase 2

The Enhanced Angiogenic Cell Therapy - Acute Myocardial Infarction Trial

Active, not recruitingNCT00936819

Ottawa Hospital Research InstituteAnterior Wall Myocardial Infarction

Start: 2013-07-19End: 2029-11-30Updated: 2025-08-15

Study of Angiogenic Cell Therapy for Progressive Pulmonary Hypertension

TerminatedNCT03001414

Northern TherapeuticsHypertension,Pulmonary

Start: 2017-09-28End: 2023-11-01Updated: 2025-01-31

Related Papers

Abstract 4141662: Study of Angiogenic Cell Therapy for Progressive Pulmonary Hypertension: Intervention with Repeat dosing of eNOS-enhanced EPCs: the SAPPHIRE Trial

Circulation2024-11-121 citations